Case Report

Published on 20 Nov 2024

Case report: Tracing in parallel the salivary and gut microbiota profiles to assist Larotrectinib anticancer treatment for NTRK fusion–positive glioblastoma

in Pharmacology of Anti-Cancer Drugs

Luigia Turco
Rosa Della Monica
Pasqualina Giordano
Mariella Cuomo
Manuele Biazzo
Baptiste Mateu
Raimondo Di Liello
Bruno Daniele
Nicola Normanno
Antonella De Luca

Frontiers in Oncology

doi 10.3389/fonc.2024.1458990

124 views

Original Research

Accepted on 19 Nov 2024

Cutaneous adverse events due to Checkpoint inhibitors – A retrospective analysis at a tertiary referral hospital in Switzerland 2019-2022.

in Pharmacology of Anti-Cancer Drugs

Clara Theresa Furrer-Matcau
Chloé Sieber
Dirk Lehnick
Christoph Urs Brand
Balthasar Hug

Frontiers in Oncology

doi 10.3389/fonc.2024.1485594

Editorial

Accepted on 18 Nov 2024

Editorial: Photodynamic Therapy: Challenges and Innovations for Treating Cancer

in Pharmacology of Anti-Cancer Drugs

Newton Soares Da Silva
Juliana Ferreira-Strixino
Cristina Pacheco-Soares

Frontiers in Oncology

doi 10.3389/fonc.2024.1526550

Editorial

Accepted on 18 Nov 2024

Editorial: DNA Methylation in Cancer Therapy: Therapeutic Targets and Molecular Mechanism

in Pharmacology of Anti-Cancer Drugs

Guoyi Yan
Shaofeng Duan
Jinyang Cai

Frontiers in Oncology

doi 10.3389/fonc.2024.1508214

Correction

Accepted on 18 Nov 2024

Corrigendum: Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling

in Pharmacology of Anti-Cancer Drugs

JiaHui Wu
Xiao He
Ziwei Xiong
Lingyu Shi
Daofeng Chen
Yulin Feng
Quan Wen

Frontiers in Oncology

doi 10.3389/fonc.2024.1515205

Review

Published on 12 Nov 2024

Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects

in Pharmacology of Anti-Cancer Drugs

Parminder Kaur
Pankaj Sharma
Prateek Bhatia
Minu Singh

Frontiers in Oncology

doi 10.3389/fonc.2024.1445794

217 views

Review

Accepted on 08 Nov 2024

Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer

in Pharmacology of Anti-Cancer Drugs

Zhe Zhu
Wenjing Xuan
Chaohui Wang
Chancan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1481777

Original Research

Published on 08 Nov 2024

Mechanism of luteolin against non-small-cell lung cancer: a study based on network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments

in Pharmacology of Anti-Cancer Drugs

Jihang Zhang
Changling Li
Wenyi Li
Zhenpeng Shi
Zhenguo Liu
Junyu Zhou
Jing Tang
Zixuan Ren
Yun Qiao
Deshan Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1471109

249 views

Correction

Accepted on 31 Oct 2024

A Corrigendum on Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells

in Pharmacology of Anti-Cancer Drugs

Lingling Si
Qiusheng Zheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1472829

Original Research

Accepted on 30 Oct 2024

Pembrolizumab versus Sintilimab in patients with advanced NSCLC: a retrospective multicenter study with propensity-score matching analysis

in Pharmacology of Anti-Cancer Drugs

Zhengzheng Xia
Zhuoshi Lian
Huali Xie
Ziyuan Zhou
Tujia Chen
Jun Meng
Jun Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1422039

Correction

Published on 28 Oct 2024

Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis

in Pharmacology of Anti-Cancer Drugs

Kaushiki Chatterjee
Sumit Mukherjee
Jonathan Vanmanen
Probal Banerjee
Jimmie E. Fata

Frontiers in Oncology

doi 10.3389/fonc.2024.1483410

210 views

Correction

Accepted on 27 Oct 2024

Long Non-Coding RNA SNHG1 Regulates the Wnt/b-Catenin and PI3K/AKT/mTOR Signaling Pathways via EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell

in Pharmacology of Anti-Cancer Drugs

Junyi Chen
Fubo Wang
Huan Xu
Lingfan Xu
Dong Chen
Jialiang Wang
Sihuai Huang
Yiqun Wen
Longmin Fang

Frontiers in Oncology

doi 10.3389/fonc.2024.1501882

Review

Published on 23 Oct 2024

Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?

in Pharmacology of Anti-Cancer Drugs

Shadiya Fawzul Ameer
Muna Yusuf Mohamed
Qubaa Ahmed Elzubair
Elham Abdullatif M. Sharif
Wisam Nabeel Ibrahim

Frontiers in Oncology

doi 10.3389/fonc.2024.1438040

699 views

Editorial

Published on 18 Oct 2024

Editorial: Novel drug discovery and design in acute myeloid leukemia: from bench to bedside

in Pharmacology of Anti-Cancer Drugs

Yan-Lai Tang
Zhenhua Chen
Xue-Qun Luo

Frontiers in Oncology

doi 10.3389/fonc.2024.1449636

444 views

Original Research

Published on 18 Oct 2024

Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma

in Pharmacology of Anti-Cancer Drugs

Zhongyi Zhang
Mei Zhao
Zubing Zhou
Xiaodan Ren
Yunliang He
Tao Shen
Hongping Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1471267

539 views

Editorial

Published on 10 Oct 2024

Editorial: Metals in cancer: from intracellular signaling to therapy

in Pharmacology of Anti-Cancer Drugs

Katia Aquilano
Giuseppe Filomeni
Raffaella Faraonio
Anastasia De Luca

Frontiers in Oncology

doi 10.3389/fonc.2024.1495825

245 views

Navigation group

Articles

Case report: Tracing in parallel the salivary and gut microbiota profiles to assist Larotrectinib anticancer treatment for NTRK fusion–positive glioblastoma

Cutaneous adverse events due to Checkpoint inhibitors – A retrospective analysis at a tertiary referral hospital in Switzerland 2019-2022.

Editorial: Photodynamic Therapy: Challenges and Innovations for Treating Cancer

Editorial: DNA Methylation in Cancer Therapy: Therapeutic Targets and Molecular Mechanism

Corrigendum: Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling

Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects

Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer

Mechanism of luteolin against non-small-cell lung cancer: a study based on network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments

A Corrigendum on Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells

Pembrolizumab versus Sintilimab in patients with advanced NSCLC: a retrospective multicenter study with propensity-score matching analysis

Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis

Long Non-Coding RNA SNHG1 Regulates the Wnt/b-Catenin and PI3K/AKT/mTOR Signaling Pathways via EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell

Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?

Editorial: Novel drug discovery and design in acute myeloid leukemia: from bench to bedside

Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma

Editorial: Metals in cancer: from intracellular signaling to therapy